好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Twelve Months of Nightly Eszopiclone Treatment in Patients with Chronic Insomnia: Assessment of Long-Term Efficacy and Safety
Sleep
(-)
059
Authors/Disclosures
Shailee S. Shah, MD Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Zehra Husain, MD Dr. Husain has a non-compensated relationship as a member, Medical Board of Directors with Epilepsy Foundation of Eastern Pennsylvania that is relevant to AAN interests or activities.
Matthew Remz, MD (University of Florida) Dr. Remz has nothing to disclose.
Jonathan Cheponis, MD (Lehigh Valley Health Network) Dr. Cheponis has nothing to disclose.
No disclosure on file
No disclosure on file